Toronto, Ontario, December 19, 2014 – Today, Ontario Bioscience Innovation Organization (OBIO®) released a statement commending the Government and the Ontario Health Innovation Council (OHIC) for their work to improve health innovation adoption in the province.
“OBIO congratulates OHIC on their work of the past year and is pleased to support the recommendations in their final report” said Gail Garland, Chief Executive Officer of OBIO. “Addressing the issues of value based procurement and adopting and disseminating innovative health technologies throughout the province has the potential to improve patient outcomes and control costs. When industry is a partner in health innovation discussions, there is further potential to contribute to economic growth.”
Innovation adoption has been a key initiative for OBIO. During 2013 OBIO successfully built a healthcare industry coalition, consulted with Industry and government and prepared an economic analysis of innovative technologies that have been adopted in other parts of the world but were delayed or failed completely to gain access to the Ontario healthcare system. The outcome is contained in OBIO’s 2013 report “Realizing the Promise of Healthcare Innovation in Ontario” Recently, OBIO has been working on a common transparent definition of value for use in technology research and reviews.
OBIO’s other two lead programs are achieving measurable outcomes for Ontario human health technology and bioscience companies. The OBIO Capital Access Advisory Program (CAAP™) helps Ontario companies become “investment ready” and introduces them to a network of local and global investors while OBIO’s interconnectivity programs build sector expertise and solutions through leadership events, training and the MPP, multi-party life sciences caucus.
About OBIO® The Ontario Bioscience Innovation Organization (OBIO®) is a not-for-profit, membership-based organization engaged in the development of an integrated health innovation economy for Ontario that will become a leader in providing health technology to the international marketplace. OBIO advances this goal through advocacy, promotion and strategic leadership and via collaborative partnerships with industry, academia, patients and government.
OBIO Contact Gail Garland President and Chief Executive Officer email@example.com 416-673-6619
Click here to view the full press release.